AVALX
Price
$55.51
Change
-$0.95 (-1.68%)
Updated
Oct 9 closing price
Net Assets
868.27M
PRNEX
Price
$42.61
Change
-$0.50 (-1.16%)
Updated
Oct 9 closing price
Net Assets
2.48B
Interact to see
Advertisement

AVALX vs PRNEX

Header iconAVALX vs PRNEX Comparison
Open Charts AVALX vs PRNEXBanner chart's image
Aegis Value I
Price$55.51
Change-$0.95 (-1.68%)
VolumeN/A
Net Assets868.27M
T. Rowe Price New Era
Price$42.61
Change-$0.50 (-1.16%)
VolumeN/A
Net Assets2.48B
AVALX vs PRNEX Comparison Chart in %
View a ticker or compare two or three
VS
AVALX vs. PRNEX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVALX is a Buy and PRNEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRNEX has more cash in the bank: 2.48B vs. AVALX (868M). PRNEX pays higher dividends than AVALX: PRNEX (1.81) vs AVALX (0.65). AVALX was incepted earlier than PRNEX: AVALX (27 years) vs PRNEX (57 years). AVALX (1.45) is less costly to investors than PRNEX (0.77). PRNEX is a more actively managed with annual turnover of: 24.30 vs. AVALX (9.00). PRNEX has a lower initial minimum investment than AVALX: PRNEX (2500) vs AVALX (10000). AVALX annual gain was more profitable for investors over the last year : 39.33 vs. PRNEX (4.44). AVALX return over 5 years is better than : 197.90 vs. PRNEX (63.82).
AVALXPRNEXAVALX / PRNEX
Total Expense Ratio1.450.77188%
Annual Report Gross Expense Ratio1.450.77188%
Fund Existence27 years57 years-
Gain YTD57.44614.666392%
Front LoadN/AN/A-
Min. Initial Investment100002500400%
Min. Initial Investment IRAN/AN/A-
Net Assets868M2.48B35%
Annual Yield % from dividends0.651.8136%
Returns for 1 year39.334.44886%
Returns for 3 years104.4219.13546%
Returns for 5 years197.9063.82310%
Returns for 10 years386.3064.17602%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHSAX62.83N/A
N/A
BlackRock Health Sciences Opps Inv A
AGRCX11.52N/A
N/A
AB Growth C
ETLCX15.57N/A
N/A
Eventide Large Cap Focus C
FCUCX20.20-0.10
-0.49%
NYLI PineStone U.S. Equity Class C
BRZIX13.61-0.09
-0.66%
BlackRock Sust Aware Adg Intl Eq Ins